Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 14,020 shares at $50.18 ($720K) on 2021-07-01, disclosed to the SEC on 2021-07-06.
Open-market sale of $720k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.18 | 2,400 | $120K | 16.7% |
| 2 | $51.30 | 4,127 | $212K | 29.4% |
| 3 | $51.30 | 4,127 | $212K | 29.4% |
| 4 | $52.18 | 1,473 | $77K | 10.7% |
| 5 | $52.18 | 1,473 | $77K | 10.7% |
| 6 | $53.18 | 420 |
| $22K |
| 3.1% |
| Total | $51.35 avg | 14,020 | $720K | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |